Search research articles
Contact Us
Filters
Showing results (91-100 of 142) with videos related to
Page
of 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
September 26, 2024
Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma
Bin Xu, Marina K Baine, Achim Jungbluth, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 23, 2023
Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?
Daniel W Scholfield, Joseph Lopez, Alana Eagan, et al.
Molecular Cancer Research : MCR
|
July 21, 2023
Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects
Iñigo Landa, Caitlin E M Thornton, Bin Xu, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 6, 2025
High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic Outcome
Daniel W Scholfield, Bin Xu, Helena Levyn, et al.
Human Pathology
|
September 13, 2020
Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting
Ronald Ghossein, Justine A Barletta, Martin Bullock, et al.
European Thyroid Journal
|
February 13, 2025
An anatomic checklist for accurate staging of grossly invasive thyroid cancer
Mark L Urken, Margaret Brandwein-Weber, Raymond L Chai, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 6, 2022
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer
Nancy Y Lee, Nadeem Riaz, Vanessa Wu, et al.
Cancer Research
|
May 16, 2018
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers
Brian R Untch, Vanessa Dos Anjos, Maria E R Garcia-Rendueles, et al.
Molecular Cancer Therapeutics
|
November 18, 2021
Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity
Yiyu Dong, Yongxing Gong, Fengshen Kuo, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
October 17, 2025
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCC
Gabriel Raab, Bin Xu, Anas Alabkaa, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 142) with videos related to
Sort By:
Page
of 15
The Journal of Clinical Endocrinology and Metabolism
|
September 26, 2024
Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma
Bin Xu, Marina K Baine, Achim Jungbluth, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 23, 2023
Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?
Daniel W Scholfield, Joseph Lopez, Alana Eagan, et al.
Molecular Cancer Research : MCR
|
July 21, 2023
Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects
Iñigo Landa, Caitlin E M Thornton, Bin Xu, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 6, 2025
High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic Outcome
Daniel W Scholfield, Bin Xu, Helena Levyn, et al.
Human Pathology
|
September 13, 2020
Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting
Ronald Ghossein, Justine A Barletta, Martin Bullock, et al.
European Thyroid Journal
|
February 13, 2025
An anatomic checklist for accurate staging of grossly invasive thyroid cancer
Mark L Urken, Margaret Brandwein-Weber, Raymond L Chai, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 6, 2022
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer
Nancy Y Lee, Nadeem Riaz, Vanessa Wu, et al.
Cancer Research
|
May 16, 2018
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers
Brian R Untch, Vanessa Dos Anjos, Maria E R Garcia-Rendueles, et al.
Molecular Cancer Therapeutics
|
November 18, 2021
Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity
Yiyu Dong, Yongxing Gong, Fengshen Kuo, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
October 17, 2025
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCC
Gabriel Raab, Bin Xu, Anas Alabkaa, et al.
Page
of 15